Sign in to continue:

Monday, April 13th, 2026

ValueMax Group Issues 496,500 New Shares After Warrant Exercise at S$0.36 Each

Important Information for Shareholders and Potential Price Sensitivity

  • Share Dilution: The issuance of new shares will marginally dilute existing shareholders, as the total share count has increased. While the dilution is minor (about 0.05%), investors should note that further warrant exercises could lead to additional dilution.
  • Potential Capital Raise: The exercise price of S\$0.36 per warrant implies that the Company has raised approximately S\$178,740 (496,500 x S\$0.36) from this warrant exercise. If all outstanding warrants are exercised, ValueMax could potentially raise an additional S\$1,051,630 (2,921,196 x S\$0.36).
  • Future Share Issuance: The remaining 2,921,196 warrants represent a potential future increase in share capital and further dilution. The expiry date of these warrants (14 September 2026) is an important timeline for investors to monitor.
  • Market Impact: The listing of new shares and potential for further warrant exercises could influence trading volumes and share price, particularly if warrant holders exercise in bulk closer to expiry.
  • Parity with Existing Shares: Since the new shares are issued pari passu, they will have the same rights and benefits as existing shares, including dividends and voting rights.

Additional Details

  • Execution Date: The warrant exercise and share issuance occurred on 13 April 2026.
  • Company Secretary: The announcement was made by Lotus Isabella Lim Mei Hua, Company Secretary.
  • Treasury Shares: The Company still holds 100,000 treasury shares, which are not part of the issued share count.

Investor Takeaways

  • This announcement signals active participation by warrant holders, which may indicate confidence in the Company’s prospects.
  • Shareholders should be aware of the potential for further dilution in the coming months as more warrants may be exercised.
  • The Company’s ability to raise capital via warrant exercises can be positive for growth initiatives but may weigh on share price if dilution concerns rise.
  • Key dates to monitor are 15 April 2026 (listing of new shares) and 14 September 2026 (warrant expiry).

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult their financial advisors before making any investment decisions. The information provided reflects publicly available disclosures as of the announcement date and may be subject to change.

View ValueMax W260914 Historical chart here



   Ad